These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2952126)

  • 41. Structure-activity relationships for the inhibition of plasmin and plasminogen activation by aromatic diamidines and a study of the effect of plasma proteins on the inhibition process.
    Geratz JD
    Thromb Diath Haemorrh; 1973 Feb; 29(1):154-67. PubMed ID: 4267737
    [No Abstract]   [Full Text] [Related]  

  • 42. p-Aminobenzamidine as a fluorescent probe for the active site of serine proteases.
    Evans SA; Olson ST; Shore JD
    J Biol Chem; 1982 Mar; 257(6):3014-7. PubMed ID: 7037776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of the haemolytic complement activity by derivatives of benzamidine.
    Hauptmann J; Markwardt F
    Biochem Pharmacol; 1977 Feb; 26(4):325-9. PubMed ID: 849323
    [No Abstract]   [Full Text] [Related]  

  • 44. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
    Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
    ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
    Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
    Tidwell RR; Geratz JD; Dubovi EJ
    J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. N1-substituted benzamidines: synthesis, antiproteinase activity and inhibition of tumor cell growth.
    Ferroni R; Simoni D; Binato G; Nastruzzi C; Manfredini S; Orlandini P; Feriotto G; Gambari R
    Farmaco; 1991 Nov; 46(11):1311-21. PubMed ID: 1811617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selective inhibition of large-to-small surfactant aggregate conversion by serine protease inhibitors of the bis-benzamidine type.
    Ruppert C; Pucker C; Markart P; Schmidt R; Grimminger F; Seeger W; Stürzebecher J; Günther A
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):95-102. PubMed ID: 12495937
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacology of benzamidine-type thrombin inhibitors.
    Hauptmann J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.
    Katakura S; Nagahara T; Hara T; Iwamoto M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-1-antitrypsin. 3. Inhibition of trypsin, thrombin, plasmin and leucoproteinases.
    Tan BH; Gans H
    Pharm Weekbl; 1969 Jun; 104(26):717-25. PubMed ID: 4239740
    [No Abstract]   [Full Text] [Related]  

  • 53. Irreversible enzyme inhibitors. CLII. Proteolytic enzymes. X. Inhibition of guinea pig complement by substituted benzamidines.
    Baker BR; Erickson EH
    J Med Chem; 1969 May; 12(3):408-14. PubMed ID: 5788155
    [No Abstract]   [Full Text] [Related]  

  • 54. Specific adsorption of serine proteases on coated silica beads substituted with amidine derivatives.
    Khamlichi S; Muller D; Fuks R; Jozefonvicz J
    J Chromatogr; 1990 Jun; 510():123-32. PubMed ID: 2169476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Synthetic inhibitors of serine proteinases. 18. Inhibition of trypsin, plasmin and thrombin by derivatives of naphthamidine and ketone structure].
    Walsmann P; Markwardt F; Stürzebecher J; Voigt B; Wagner G
    Pharmazie; 1978 Nov; 33(11):760-1. PubMed ID: 155823
    [No Abstract]   [Full Text] [Related]  

  • 57. Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine.
    Stürzebecher J; Stürzebecher U; Markwardt F
    Toxicon; 1986; 24(6):585-95. PubMed ID: 3529503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synthetic inhibitors targeting serine and aspartic acid proteases].
    Reboud-Ravaux MC; Boggetto ND; Doucet CE; de Rosny EH; Vergely IB; Thierry NM; Amour AJ
    J Pharm Belg; 1996; 51(3):161-4. PubMed ID: 8778349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.